Nurix Therapeutics (NRIX) Net Margin (2019 - 2025)
Historic Net Margin for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to 576.13%.
- Nurix Therapeutics' Net Margin fell 1353800.0% to 576.13% in Q4 2025 from the same period last year, while for Nov 2025 it was 314.9%, marking a year-over-year increase of 399500.0%. This contributed to the annual value of 314.9% for FY2025, which is 399500.0% up from last year.
- According to the latest figures from Q4 2025, Nurix Therapeutics' Net Margin is 576.13%, which was down 1353800.0% from 1094.77% recorded in Q3 2025.
- Nurix Therapeutics' 5-year Net Margin high stood at 79.14% for Q2 2023, and its period low was 1094.77% during Q3 2025.
- Moreover, its 5-year median value for Net Margin was 380.48% (2021), whereas its average is 399.97%.
- Per our database at Business Quant, Nurix Therapeutics' Net Margin skyrocketed by 4119600bps in 2023 and then plummeted by -7058600bps in 2025.
- Nurix Therapeutics' Net Margin (Quarter) stood at 509.59% in 2021, then crashed by -35bps to 688.74% in 2022, then soared by 60bps to 276.77% in 2023, then plummeted by -59bps to 440.75% in 2024, then tumbled by -31bps to 576.13% in 2025.
- Its Net Margin stands at 576.13% for Q4 2025, versus 1094.77% for Q3 2025 and 98.66% for Q2 2025.